Item Response Theory analyses of DSM-5 substance use disorder criteria in French outpatient addiction clinic participants. How much is craving special?


Journal

Drug and alcohol dependence
ISSN: 1879-0046
Titre abrégé: Drug Alcohol Depend
Pays: Ireland
ID NLM: 7513587

Informations de publication

Date de publication:
01 07 2020
Historique:
received: 25 09 2019
revised: 15 04 2020
accepted: 16 04 2020
pubmed: 29 5 2020
medline: 2 3 2021
entrez: 29 5 2020
Statut: ppublish

Résumé

To evaluate the dimensionality and psychometric validity of the 11 DSM-5 criteria for 5 substance use disorders, with a focus on craving, and taking into account age, gender and psychiatric comorbidities in a French sample of subjects seeking addiction treatment. This cross-sectional study, included participants with DSM-5 substance use disorders that sought treatment for at least one addiction from outpatient clinics. Diagnostic criteria were evaluated with the Mini international Neuropsychiatric Interview. In Current regular user (2 times per week), factor and 2-parameter IRT analysis was used to investigate the dimensionality and psychometric properties of the 11 DSM-5 SUD criteria. Differential Item and Test functioning (DIF and DTF) analysis were performed across sociodemographic characteristics and psychiatric disorders. 1359 participants (alcohol n = 787, opiates n = 131, cocaine n = 141, tobacco n = 1014, cannabis n = 504), were included (68% male; mean age 38.7). One-factor dimensionality was confirmed, except for tobacco. Craving criterion had the strongest factor loadings, lower difficulty (range, -1.29 to -0.67) and higher discrimination (range, 2.11-3.05), and no DIF compared to other criteria. The tobacco criteria set functioned differently by mood and anxiety disorders. We confirmed the unidimensionality of the 11 SUD DSM-5 criteria and furthermore that craving was the most selective criterion because of its psychometric properties and no DIF compared to other criteria, regardless of the substance in this adult clinical sample. Unidimensionality of tobacco criteria was not confirmed, suggesting DSM-IV abuse criteria limitations as indicators of the construct.

Sections du résumé

BACKGROUND
To evaluate the dimensionality and psychometric validity of the 11 DSM-5 criteria for 5 substance use disorders, with a focus on craving, and taking into account age, gender and psychiatric comorbidities in a French sample of subjects seeking addiction treatment.
METHODS
This cross-sectional study, included participants with DSM-5 substance use disorders that sought treatment for at least one addiction from outpatient clinics. Diagnostic criteria were evaluated with the Mini international Neuropsychiatric Interview. In Current regular user (2 times per week), factor and 2-parameter IRT analysis was used to investigate the dimensionality and psychometric properties of the 11 DSM-5 SUD criteria. Differential Item and Test functioning (DIF and DTF) analysis were performed across sociodemographic characteristics and psychiatric disorders.
RESULTS
1359 participants (alcohol n = 787, opiates n = 131, cocaine n = 141, tobacco n = 1014, cannabis n = 504), were included (68% male; mean age 38.7). One-factor dimensionality was confirmed, except for tobacco. Craving criterion had the strongest factor loadings, lower difficulty (range, -1.29 to -0.67) and higher discrimination (range, 2.11-3.05), and no DIF compared to other criteria. The tobacco criteria set functioned differently by mood and anxiety disorders.
CONCLUSIONS
We confirmed the unidimensionality of the 11 SUD DSM-5 criteria and furthermore that craving was the most selective criterion because of its psychometric properties and no DIF compared to other criteria, regardless of the substance in this adult clinical sample. Unidimensionality of tobacco criteria was not confirmed, suggesting DSM-IV abuse criteria limitations as indicators of the construct.

Identifiants

pubmed: 32464467
pii: S0376-8716(20)30201-5
doi: 10.1016/j.drugalcdep.2020.108036
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108036

Subventions

Organisme : NIAAA NIH HHS
ID : R01 AA025309
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA018652
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declarations of competing interest No author reports conflicts of interest related to this work. Dr. Auriacombe reports grants from French Health Ministry Research Grant (PHRC), French Addiction Agency Research Grant (MILDT/MILDECA), Aquitaine Regional Council Research Support (CRA), during the conduct of the study; grants from Indivior, personal fees from Bouchara Recordati, Camurus, Indivior outside the submitted work; Dr. Serre reports grants and personal fees from French Government Addiction Agency MILDECA, during the conduct of the study; Dr. Hasin reports grants from NIH - NIAAA, during the conduct of the study; Dr. Kervran reports grant from French Rotary club of Saint Medard-En-Jalles and Libourne-Saint Emilion during the conduct of the study.

Auteurs

Charlotte Kervran (C)

University of Bordeaux, Phenomenology and Determinants of Appetitive Behaviors (Addiction Team), Sleep, Addiction and Neuropsychiatry Laboratory (SANPSY), USR CNRS 3413, 146 Bis Rue Léo Saignat, 33076, Bordeaux, France; Pôle Addictologie, CH Ch. Perrens and CHU de Bordeaux, 121 Rue De La Béchade, 33076, Bordeaux, France.

Dvora Shmulewitz (D)

New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA; Department of Psychiatry, Columbia University Irving Medical Center, 1051 Riverside Drive, New York, NY 10032, USA.

Fuschia Serre (F)

University of Bordeaux, Phenomenology and Determinants of Appetitive Behaviors (Addiction Team), Sleep, Addiction and Neuropsychiatry Laboratory (SANPSY), USR CNRS 3413, 146 Bis Rue Léo Saignat, 33076, Bordeaux, France; Pôle Addictologie, CH Ch. Perrens and CHU de Bordeaux, 121 Rue De La Béchade, 33076, Bordeaux, France.

Malki Stohl (M)

New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA.

Cécile Denis (C)

Center for Studies of Addiction, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, 3535 Market St, Suite 4000, Philadelphia, PA 19104, USA; University of Bordeaux, Phenomenology and Determinants of Appetitive Behaviors (Addiction Team), Sleep, Addiction and Neuropsychiatry Laboratory (SANPSY), USR CNRS 3413, 146 Bis Rue Léo Saignat, 33076, Bordeaux, France.

Deborah Hasin (D)

New York State Psychiatric Institute, 1051 Riverside Drive, New York, NY 10032, USA; Department of Psychiatry, Columbia University Irving Medical Center, 1051 Riverside Drive, New York, NY 10032, USA; Department of Epidemiology, Columbia University Mailman School of Public Health, 722 West 168th Street, New York, NY 10032, USA.

Marc Auriacombe (M)

University of Bordeaux, Phenomenology and Determinants of Appetitive Behaviors (Addiction Team), Sleep, Addiction and Neuropsychiatry Laboratory (SANPSY), USR CNRS 3413, 146 Bis Rue Léo Saignat, 33076, Bordeaux, France; Pôle Addictologie, CH Ch. Perrens and CHU de Bordeaux, 121 Rue De La Béchade, 33076, Bordeaux, France; Center for Studies of Addiction, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, 3535 Market St, Suite 4000, Philadelphia, PA 19104, USA. Electronic address: marc.auriacombe@u-bordeaux.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH